Global Endoparasiticide Sales Market Report 2021

1 Endoparasiticide Market Overview

• 1.1 Endoparasiticide Product Scope
• 1.2 Endoparasiticide Segment by Type
  • 1.2.1 Global Endoparasiticide Sales by Type (2016 & 2021 & 2027)
  • 1.2.2 Ear Tags
  • 1.2.3 Tablets
  • 1.2.4 Injectables
  • 1.2.5 Feed Additives
• 1.3 Endoparasiticide Segment by Application
  • 1.3.1 Global Endoparasiticide Sales Comparison by Application (2016 & 2021 & 2027)
  • 1.3.2 Veterinary Hospitals or Clinics
  • 1.3.3 Animal Farms
  • 1.3.4 Home Care Settings
• 1.4 Endoparasiticide Market Estimates and Forecasts (2016-2027)
  • 1.4.1 Global Endoparasiticide Market Size in Value Growth Rate (2016-2027)
  • 1.4.2 Global Endoparasiticide Market Size in Volume Growth Rate (2016-2027)
  • 1.4.3 Global Endoparasiticide Price Trends (2016-2027)

2 Endoparasiticide Estimates and Forecasts by Region

• 2.1 Global Endoparasiticide Market Size by Region: 2016 VS 2021 VS 2027
• 2.2 Global Endoparasiticide Retrospective Market Scenario by Region (2016-2021)
  • 2.2.1 Global Endoparasiticide Sales Market Share by Region (2016-2021)
  • 2.2.2 Global Endoparasiticide Revenue Market Share by Region (2016-2021)
• 2.3 Global Endoparasiticide Market Estimates and Forecasts by Region (2022-2027)
  • 2.3.1 Global Endoparasiticide Sales Estimates and Forecasts by Region (2022-2027)
  • 2.3.2 Global Endoparasiticide Revenue Forecast by Region (2022-2027)
• 2.4 Geographic Market Analysis: Market Facts & Figures
  • 2.4.1 North America Endoparasiticide Estimates and Projections (2016-2027)
  • 2.4.2 Europe Endoparasiticide Estimates and Projections (2016-2027)
  • 2.4.3 China Endoparasiticide Estimates and Projections (2016-2027)
  • 2.4.4 Japan Endoparasiticide Estimates and Projections (2016-2027)
  • 2.4.5 Southeast Asia Endoparasiticide Estimates and Projections (2016-2027)
  • 2.4.6 India Endoparasiticide Estimates and Projections (2016-2027)

3 Global Endoparasiticide Competition Landscape by Players

• 3.1 Global Top Endoparasiticide Players by Sales (2016-2021)
• 3.2 Global Top Endoparasiticide Players by Revenue (2016-2021)
• 3.3 Global Endoparasiticide Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Endoparasiticide as of 2020)
• 3.4 Global Endoparasiticide Average Price by Company (2016-2021)
• 3.5 Manufacturers Endoparasiticide Manufacturing Sites, Area Served, Product Type
• 3.6 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Global Endoparasiticide Market Size by Type

• 4.1 Global Endoparasiticide Historic Market Review by Type (2016-2021)
  • 4.1.1 Global Endoparasiticide Sales Market Share by Type (2016-2021)
  • 4.1.2 Global Endoparasiticide Revenue Market Share by Type (2016-2021)
  • 4.1.3 Global Endoparasiticide Price by Type (2016-2021)
• 4.2 Global Endoparasiticide Market Estimates and Forecasts by Type (2022-2027)
  • 4.2.1 Global Endoparasiticide Sales Forecast by Type (2022-2027)
  • 4.2.2 Global Endoparasiticide Revenue Forecast by Type (2022-2027)
  • 4.2.3 Global Endoparasiticide Price Forecast by Type (2022-2027)

5 Global Endoparasiticide Market Size by Application

• 5.1 Global Endoparasiticide Historic Market Review by Application (2016-2021)
  • 5.1.1 Global Endoparasiticide Sales Market Share by Application (2016-2021)
  • 5.1.2 Global Endoparasiticide Revenue Market Share by Application (2016-2021)
  • 5.1.3 Global Endoparasiticide Price by Application (2016-2021)
• 5.2 Global Endoparasiticide Market Estimates and Forecasts by Application (2022-2027)
  • 5.2.1 Global Endoparasiticide Sales Forecast by Application (2022-2027)
  • 5.2.2 Global Endoparasiticide Revenue Forecast by Application (2022-2027)
  • 5.2.3 Global Endoparasiticide Price Forecast by Application (2022-2027)

6 North America Endoparasiticide Market Facts & Figures

• 6.1 North America Endoparasiticide Sales by Company
  • 6.1.1 North America Endoparasiticide Sales by Company (2016-2021)
  • 6.1.2 North America Endoparasiticide Revenue by Company (2016-2021)
• 6.2 North America Endoparasiticide Sales Breakdown by Type
  • 6.2.1 North America Endoparasiticide Sales Breakdown by Type (2016-2021)
  • 6.2.2 North America Endoparasiticide Sales Breakdown by Type (2022-2027)
• 6.3 North America Endoparasiticide Sales Breakdown by Application
  • 6.3.1 North America Endoparasiticide Sales Breakdown by Application (2016-2021)
  • 6.3.2 North America Endoparasiticide Sales Breakdown by Application (2022-2027)

7 Europe Endoparasiticide Market Facts & Figures

• 7.1 Europe Endoparasiticide Sales by Company
  • 7.1.1 Europe Endoparasiticide Sales by Company (2016-2021)
  • 7.1.2 Europe Endoparasiticide Revenue by Company (2016-2021)
• 7.2 Europe Endoparasiticide Sales Breakdown by Type
  • 7.2.1 Europe Endoparasiticide Sales Breakdown by Type (2016-2021)
  • 7.2.2 Europe Endoparasiticide Sales Breakdown by Type (2022-2027)
• 7.3 Europe Endoparasiticide Sales Breakdown by Application
  • 7.3.1 Europe 133 Sales Breakdown by Application (2016-2021)
  • 7.3.2 Europe 133 Sales Breakdown by Application (2022-2027)

8 China Endoparasiticide Market Facts & Figures

• 8.1 China Endoparasiticide Sales by Company
  • 8.1.1 China Endoparasiticide Sales by Company (2016-2021)
  • 8.1.2 China Endoparasiticide Revenue by Company (2016-2021)
• 8.2 China Endoparasiticide Sales Breakdown by Type
  • 8.2.1 China Endoparasiticide Sales Breakdown by Type (2016-2021)
  • 8.2.2 China Endoparasiticide Sales Breakdown by Type (2022-2027)
• 8.3 China Endoparasiticide Sales Breakdown by Application
  • 8.3.1 China 242 Sales Breakdown by Application (2016-2021)
  • 8.3.2 China 242 Sales Breakdown by Application (2022-2027)

9 Japan Endoparasiticide Market Facts & Figures

• 9.1 Japan Endoparasiticide Sales by Company
  • 9.1.1 Japan Endoparasiticide Sales by Company (2016-2021)
  • 9.1.2 Japan Endoparasiticide Revenue by Company (2016-2021)
• 9.2 Japan Endoparasiticide Sales Breakdown by Type
  • 9.2.1 Japan Endoparasiticide Sales Breakdown by Type (2016-2021)
  • 9.2.2 Japan Endoparasiticide Sales Breakdown by Type (2022-2027)
• 9.3 Japan Endoparasiticide Sales Breakdown by Application
  • 9.3.1 Japan Feb. Sales Breakdown by Application (2016-2021)
  • 9.3.2 Japan Feb. Sales Breakdown by Application (2022-2027)

10 Southeast Asia Endoparasiticide Market Facts & Figures

• 10.1 Southeast Asia Endoparasiticide Sales by Company
  • 10.1.1 Southeast Asia Endoparasiticide Sales by Company (2016-2021)
  • 10.1.2 Southeast Asia Endoparasiticide Revenue by Company (2016-2021)
• 10.2 Southeast Asia Endoparasiticide Sales Breakdown by Type
  • 10.2.1 Southeast Asia Endoparasiticide Sales Breakdown by Type (2016-2021)
  • 10.2.2 Southeast Asia Endoparasiticide Sales Breakdown by Type (2022-2027)
• 10.3 Southeast Asia Endoparasiticide Sales Breakdown by Application
  • 10.3.1 Southeast Asia K Units Sales Breakdown by Application (2016-2021)
  • 10.3.2 Southeast Asia K Units Sales Breakdown by Application (2022-2027)

11 India Endoparasiticide Market Facts & Figures

• 11.1 India Endoparasiticide Sales by Company
  • 11.1.1 India Endoparasiticide Sales by Company (2016-2021)
  • 11.1.2 India Endoparasiticide Revenue by Company (2016-2021)
• 11.2 India Endoparasiticide Sales Breakdown by Type
  • 11.2.1 India Endoparasiticide Sales Breakdown by Type (2016-2021)
  • 11.2.2 India Endoparasiticide Sales Breakdown by Type (2022-2027)
• 11.3 India Endoparasiticide Sales Breakdown by Application
  • 11.3.1 India Endoparasiticide Sales Breakdown by Application (2016-2021)
  • 11.3.2 India Endoparasiticide Sales Breakdown by Application (2022-2027)

12 Company Profiles and Key Figures in Endoparasiticide Business

• 12.1 Boehringer Ingelheim
  • 12.1.1 Boehringer Ingelheim Corporation Information
  • 12.1.2 Boehringer Ingelheim Business Overview
  • 12.1.3 Boehringer Ingelheim Endoparasiticide Sales, Revenue and Gross Margin (2016-2021)
  • 12.1.4 Boehringer Ingelheim Endoparasiticide Products Offered
  • 12.1.5 Boehringer Ingelheim Recent Development
• 12.2 Elanco
  • 12.2.1 Elanco Corporation Information
  • 12.2.2 Elanco Business Overview
  • 12.2.3 Elanco Endoparasiticide Sales, Revenue and Gross Margin (2016-2021)
  • 12.2.4 Elanco Endoparasiticide Products Offered
  • 12.2.5 Elanco Recent Development
• 12.3 Zoetis
  • 12.3.1 Zoetis Corporation Information
  • 12.3.2 Zoetis Business Overview
  • 12.3.3 Zoetis Endoparasiticide Sales, Revenue and Gross Margin (2016-2021)
  • 12.3.4 Zoetis Endoparasiticide Products Offered
  • 12.3.5 Zoetis Recent Development
• 12.4 Merck
  • 12.4.1 Merck Corporation Information
  • 12.4.2 Merck Business Overview
  • 12.4.3 Merck Endoparasiticide Sales, Revenue and Gross Margin (2016-2021)
  • 12.4.4 Merck Endoparasiticide Products Offered
  • 12.4.5 Merck Recent Development
• 12.5 Virbac
  • 12.5.1 Virbac Corporation Information
  • 12.5.2 Virbac Business Overview
  • 12.5.3 Virbac Endoparasiticide Sales, Revenue and Gross Margin (2016-2021)
  • 12.5.4 Virbac Endoparasiticide Products Offered
  • 12.5.5 Virbac Recent Development
• 12.6 Novartis AG
  • 12.6.1 Novartis AG Corporation Information
  • 12.6.2 Novartis AG Business Overview
  • 12.6.3 Novartis AG Endoparasiticide Sales, Revenue and Gross Margin (2016-2021)
  • 12.6.4 Novartis AG Endoparasiticide Products Offered
  • 12.6.5 Novartis AG Recent Development
• 12.7 Ceva Sante Animlae
  • 12.7.1 Ceva Sante Animlae Corporation Information
  • 12.7.2 Ceva Sante Animlae Business Overview
  • 12.7.3 Ceva Sante Animlae Endoparasiticide Sales, Revenue and Gross Margin (2016-2021)
  • 12.7.4 Ceva Sante Animlae Endoparasiticide Products Offered
  • 12.7.5 Ceva Sante Animlae Recent Development
• 12.8 Bayer AG
  • 12.8.1 Bayer AG Corporation Information
  • 12.8.2 Bayer AG Business Overview
  • 12.8.3 Bayer AG Endoparasiticide Sales, Revenue and Gross Margin (2016-2021)
  • 12.8.4 Bayer AG Endoparasiticide Products Offered
  • 12.8.5 Bayer AG Recent Development
• 12.9 Eli Lilly
  • 12.9.1 Eli Lilly Corporation Information
  • 12.9.2 Eli Lilly Business Overview
  • 12.9.3 Eli Lilly Endoparasiticide Sales, Revenue and Gross Margin (2016-2021)
  • 12.9.4 Eli Lilly Endoparasiticide Products Offered
  • 12.9.5 Eli Lilly Recent Development
• 12.10 Vetoquinol
  • 12.10.1 Vetoquinol Corporation Information
  • 12.10.2 Vetoquinol Business Overview
  • 12.10.3 Vetoquinol Endoparasiticide Sales, Revenue and Gross Margin (2016-2021)
  • 12.10.4 Vetoquinol Endoparasiticide Products Offered
  • 12.10.5 Vetoquinol Recent Development

13 Endoparasiticide Manufacturing Cost Analysis

• 13.1 Endoparasiticide Key Raw Materials Analysis
  • 13.1.1 Key Raw Materials
  • 13.1.2 Key Raw Materials Price Trend
  • 13.1.3 Key Suppliers of Raw Materials
• 13.2 Proportion of Manufacturing Cost Structure
• 13.3 Manufacturing Process Analysis of Endoparasiticide
• 13.4 Endoparasiticide Industrial Chain Analysis

14 Marketing Channel, Distributors and Customers

• 14.1 Marketing Channel
• 14.2 Endoparasiticide Distributors List
• 14.3 Endoparasiticide Customers

15 Market Dynamics

• 15.1 Endoparasiticide Market Trends
• 15.2 Endoparasiticide Drivers
• 15.3 Endoparasiticide Market Challenges
• 15.4 Endoparasiticide Market Restraints

16 Research Findings and Conclusion

17 Appendix

• 17.1 Research Methodology
  • 17.1.1 Methodology/Research Approach
  • 17.1.2 Data Source
• 17.2 Author List